Is PLx Pharma (PLXP) A Worthy Investment?
Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Plx Pharma Inc. (PLXP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Park West Asset Management Peter S. Park | 0 | $0 | -100% | 0% |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.65 | 4,100 | Officer, Director | 5,186 | 2022-03-15 | Filing | |
| $3.65 | 3,700 | Officer | 26,670 | 2022-03-15 | Filing | |
| $3.66 | 10,000 | Officer | 22,970 | 2022-03-15 | Filing | |
| $12.51 | 120 | Officer, Director | 494,690 | 2021-06-14 | Filing | |
| $12.50 | 5,080 | Officer, Director | 494,570 | 2021-06-14 | Filing |
Institutional Investors' Holdings
News See All
10 Healthcare Stocks to Buy According to Peter S. Park's Park West Asset Management
In this article, we discuss the 10 healthcare stocks to buy according to Peter S. Park's Park West Asset Management based on Q2 holdings of the fund.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Is PLx Pharma Inc. (PLXP) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Hedge Funds Cautiously Watching PLx Pharma Inc. (PLXP)
In this article you are going to find out whether hedge funds think PLx Pharma Inc. (NASDAQ:PLXP) is a good investment right now.
Hedge Funds Have Never Been More Bullish On PLx Pharma Inc. (PLXP)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through November 22nd.
Hedge Fund and Insider Trading News: David Einhorn, Marshall Wace LLP, Ra Pharmaceuticals Inc (RARX), PLx Pharma Inc (PLXP), Opko Health Inc. (OPK), and More
David Einhorn closed out 2018 with his biggest annual loss ever for the 22-year-old Greenlight Capital.
13D Filing: Park West Asset Management and PLX Pharma Inc. (PLXP)
PLX Pharma Inc. (NASDAQ:PLXP): Peter S. Park's Park West Asset Management filed an amended 13D.
You can check out Park West Asset Management's latest holdings and filings here.
13G Filing: Park West Asset Management and PLx Pharma Inc. (PLXP)
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...